US 10639272
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted A61KA61K2039/505A61K2039/542
Quick answer
US patent 10639272 (Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rani Therapeutics, LLC
- Grant date
- Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K2039/542, A61K2039/545, A61K38/00